GENEVA, Sept. 24 -- CHOLESGEN (SHANGHAI) CO. LTD. filed a patent application (CN2026/084952) for “RNAI CONSTRUCT FOR INHIBITING EXPRESSION OF USP20 GENE AND USE THEREOF”. With publication no. WO/2026/195058, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....